MORGAN SCHAEFFER: Open Payments
NPI 1811535255 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 55 payments from 16 companies in 2025. Trend: 2023 $1,430 · 2024 $1,929 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $306 |
| BIOTRONIK INC. | 9 | $196 |
| SCPHARMACEUTICALS INC. | 7 | $167 |
| Novartis Pharmaceuticals Corporation | 4 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| Abbott Laboratories | 1 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| Alnylam Pharmaceuticals Inc. | 4 | $72 |
| Novo Nordisk Inc | 2 | $58 |
| Philips North America LLC | 3 | $55 |
Products named: WATCHMAN FLX, AMVIA EDGE, FUROSCIX, LEQVIO, JARDIANCE, CARDIOMEMS, Wegovy, ONPATTRO.
Industry payments across SC — which companies pay providers there.
